These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 362641)

  • 1. B-cell antibodies and clinical kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Sep; 10(3):599-601. PubMed ID: 362641
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell alloantibodies and clinical kidney transplantation.
    Myburgh JA; Smit JA; Maier G; Meyers AM
    S Afr J Surg; 1978 Mar; 16(1):5-10. PubMed ID: 362561
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies eluted from rejected human renal allografts: specificity to B lymphocytes, monocytes, primary kidney cells, and endothelial cells.
    Lee HM; Waldrep JC; Mendez-Picon G; Mohanakumar T
    Transplant Proc; 1981 Mar; 13(1 Pt 1):108-10. PubMed ID: 7022806
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
    Nunez G; McPhaul J; Stastny P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft survival with high levels of cytotoxic antibodies.
    Feduska NJ; Amend WJ; Vincenti F; Perkins HA; Opelz G; Terasaki PI; Iwaki Y; Duca R; Dodge D; Salvatierra O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
    Hardy M; Suciu-Foca N; McKiernan T; Rohowsky C; Cianci J; Jacob J; Pierce J; Reemtsma K
    Transplant Proc; 1979 Mar; 11(1):389-92. PubMed ID: 377661
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre- and posttransplant B-cell antibodies in renal transplantation.
    Ting A; Morris PJ
    Transplant Proc; 1979 Mar; 11(1):393-6. PubMed ID: 377663
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of lymphocytotoxic antibodies on the outcome of kidney transplantation].
    Drannik GN; Driianskaia VE; Montag TS
    Urol Nefrol (Mosk); 1990; (1):28-31. PubMed ID: 2336753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of B and T cell antibodies in kidney transplantation.
    Lenhard V; Rettwitz W; Dreikorn K; Röhl L
    Proc Eur Dial Transplant Assoc; 1980; 17():478-82. PubMed ID: 7017693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
    Hirschberg H; Moen T; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
    Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic antibodies to B lymphocytes in kidney transplant patients.
    Luciani G; Castagneto M; Monari C; Renna E
    Transplant Proc; 1979 Jun; 11(2):1265-6. PubMed ID: 382503
    [No Abstract]   [Full Text] [Related]  

  • 14. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantibodies eluted from rejected human renal allografts: reactivity to primary kidney cells in culture.
    Mohanakumar T; Phibbs M; Haar J; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1980 Sep; 12(3 Suppl 1):65-68. PubMed ID: 7001704
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to endothelial antigens in eluates of 88 human kidneys: correlation with graft survival and presence of T- and B-cell antibodies.
    Baldwin WM; Soulillou JP; Claas FH; Peyrat MA; van Es LA; van Rood JJ
    Transplant Proc; 1981 Sep; 13(3):1547-50. PubMed ID: 7029812
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 18. The positive B-cell cross-match: a marker of active enhancement?
    d'Apice AJ; Tait BD
    Transplant Proc; 1979 Mar; 11(1):954-7. PubMed ID: 377728
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.
    Suthanthiran M; Fotino M; Gibofsky A; Cheigh JS; Stenzel KH; Rubin AL; Novogrodsky A
    Transplant Proc; 1979 Jun; 11(2):1263-4. PubMed ID: 382502
    [No Abstract]   [Full Text] [Related]  

  • 20. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
    Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
    Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.